In Ontario long-term care homes, antipsychotic medications play a crucial role in treating behavioral symptoms, such as agitation and aggression, that are associated with psychosis or dementia. However, the use of antipsychotic medications has become a subject of controversy, both within the province and globally, due to their potential adverse effects, which include sedation, increased fall risk, and a slightly elevated risk of death. Family members of residents are often concerned when they witness these effects – loved ones struggling to communicate or experiencing prolonged periods of drowsiness – but, for some residents, not taking these medications can lead to behaviours that pose risks to themselves and others around them.
Key Resources